A high throughput drug screening paradigm using transgenic Caenorhabditis elegans model of Alzheimer's disease
10.1016/j.tma.2019.12.002
Saved in:
Main Authors: | Teo, E., Lim, S.Y.J., Fong, S., Larbi, A., Wright, G.D., Tolwinski, N., Gruber, J. |
---|---|
Other Authors: | YALE-NUS COLLEGE |
Format: | Article |
Published: |
KeAi Communications Co.
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198969 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
ALZHEIMER DISEASE (AD) MECHANISMS AND INTERVENTIONS: INSIGHTS FROM TRANSGENIC CAENORHABDITIS ELEGANS MODEL
by: EMELYNE TEO JIA WEI
Published: (2019) -
Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans
by: Gruber, J., et al.
Published: (2011) -
Ageing in nematodes: Do antioxidants extend lifespan in Caenorhabditis elegans?
by: Pun, P.B.L., et al.
Published: (2011) -
Deceptively simple but simply deceptive - Caenorhabditis elegans lifespan studies: Considerations for aging and antioxidant effects
by: Gruber, J., et al.
Published: (2011) -
Mechanochemical Control of Symmetry Breaking in the Caenorhabditis elegans Zygote
by: Gan, Wan Jun, et al.
Published: (2022)